APRE financials

Aprea Therapeutics (APRE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

APRE income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$13.23M-$12.60M-1.93
2024––-$14.32M-$12.96M-2.35
2023––-$15.47M-$14.29M-3.95
2022––-$113.39M-$112.66M-67.99
2021––-$37.45M-$37.13M-34.88
2020–––-$53.48M-50.61